Concert's CEO will participate in a fireside chat in connection with the Jefferies Virtual Healthcare Conference on June 2 at 2:00 PM.
Concert's CEO will participate in a fireside chat in connection with the Jefferies Virtual Healthcare Conference on June 2 at 2:00 PM.
Concert Pharmaceuticals (CNCE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Subaru XV Review - The Impreza-based SUV | Finder

06:19am, Wednesday, 13'th May 2020
It's an Impreza-based SUV, with AWD, a trademark Boxer engine, the option of a hybrid, beefy suspension and ground clearance, and a well-reviewed off-road mode.
Q1 2020 Concert Pharmaceuticals Inc Earnings Call
The wider £200m Pall Mall development will include a 284-bed hotel and 400,000 sq ft of office space once complete
Concert will present a corporate overview at the 2020 UBS Virtual Global Healthcare Conference on May 19, 2020 at 3:00 p.m. ET.
Concert will present a corporate overview at the 2020 UBS Virtual Global Healthcare Conference on May 19, 2020 at 3:00 p.m. ET.
Electro-IT and Home & Deco online retailers take up approximately 370,000 square meters (sqm) of storage space and this volume could increase by at

98 Biggest Movers From Friday

12:00am, Monday, 04'th May 2020
Good morning and welcome to Concert Pharmaceuticals' first quarter 2020 investor update. Joining me this morning with prepared remarks are Roger Tung, our President and CEO; Jim Cassella, our Chief D
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Concert Pharma (CNCE), with a price target of $18.00. The
Concert (CNCE) delivered earnings and revenue surprises of 5.41% and -65.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE